发明名称 Anti-cancer cyclopenta [G]quinazoline compounds
摘要 Cyclopenta[g]quinazolines of the formula (I):-wherein: A is a group OR or NR<SUP>0</SUP>R<SUP>1 </SUP>wherein R<SUP>0 </SUP>and R<SUP>1 </SUP>are each independently hydrogen C<SUB>1-4 </SUB>alkyl, C<SUB>3-4 </SUB>alkenyl, C<SUB>3-4 </SUB>alkynyl, C<SUB>2-4 </SUB>hydroxyalkyl, C<SUB>2-4 </SUB>halogenoalkyl or C<SUB>1-4 </SUB>cyanoalkyl, or R<SUP>0 </SUP>and R<SUP>1 </SUP>together with the intermediate N form a five- or six-membered heterocyclic ring, p is an integer in the range 1 to 4, R<SUP>2 </SUP>is hydrogen, C<SUB>1-4 </SUB>alkyl, C<SUB>3-4 </SUB>alkenyl, C<SUB>3-4 </SUB>alkynyl, C<SUB>2-4 </SUB>hydroxyalkyl, C<SUB>2-4 </SUB>halogenoalkyl or C<SUB>1-4 </SUB>cyanoalkyl; Ar<SUP>1 </SUP>is phenylene, thiophenediyl, thiazolediyl, pyridinediyl or pyrimidinediyl which may optionally bear one or two substituents selected from halogeno, hydroxy, amino, nitro, cyano, trifluoromethyl, C<SUB>1-4 </SUB>alkyl and C<SUB>1-4 </SUB>alkoxy, and R<SUP>3 </SUP>is a group of one of the following formulae: -A<SUP>1</SUP>-Ar<SUP>2</SUP>-A<SUP>2</SUP>-Y<SUP>1</SUP>-A<SUP>5</SUP>-CON(R)CH(Y<SUP>4</SUP>)Y<SUP>5</SUP>-A<SUP>8</SUP>-X-Ar<SUP>4 </SUP>and pharmaceutically acceptable salts or esters thereof are of therapeutic value particularly in the treatment of cancer
申请公布号 US7297701(B2) 申请公布日期 2007.11.20
申请号 US20040487871 申请日期 2004.07.16
申请人 BTG INTERNATIONAL LIMITED 发明人 BAVETSIAS VASILIOS;JACKMAN ANN L
分类号 A01N43/54;C07D239/70;A61K;A61K31/505;A61K31/517;A61K31/519;A61K38/05;A61P;A61P35/00;C07D;C07D239/00;C07D239/90;C07D403/12;C07D471/00;C07D487/00;C07K;C07K5/02;C07K5/027 主分类号 A01N43/54
代理机构 代理人
主权项
地址